medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Number 619

<< Back

Rev Med Cos Cen 2016; 73 (619)

Enfermedad de Crohn

Villegas SLR, Marchena VEA, García GLA, Trejos HJ, González CD, Poveda RCA

Language: Spanish
References: 22
Page: 423-428
PDF size: 494.05 Kb.


ABSTRACT

Crohn’s disease is a complex clinical entity, chronic and unpredictable evolution, which is considered within the inflammatory conditions that involves the terminal ileum more often but can make other sectors of the digestive tract (jejunum, colon, stomach) and which has general effects on different systems of the body. Every time are clarifying aspects of its pathogenesis; is considered probable involvement of environmental triggers of undetermined nature (snuff, infections, dietary components, etc.). Thus, in genetically predisposed patients, intestinal mucosa would begin and perpetuate immune complex, exaggerated and uncontrolled response, primarily mediated by T lymphocytes against luminal antigens, including bacterial enteric microflora. It occurs as a chronic inflammatory process that leads to a thickening of all layers of the intestine. The terminal ileum as the only location is at 30% but no injuries often ileocecal valve and colon and coming right forms of presentation with ileal constitute 70% commitment. Less frequently can compromise in other areas of the small intestine jejunum and ileum. The lesions may be single or multiple separated by areas unchanged.


REFERENCES

  1. Bel S, García V, García D, Aparicio G. Linfedema vulvar: una manifestación infrecuente de la enfermedad de Crohn metastásica. Gastroenterol Hepatol 2001; 24: 297-299).

  2. Bergamashi R, Pessaux P, Arnaud J P: Comparison of conventional and laparoscopic ileocolic resection for Crohn’s disease. Dis Colon Rectum 2003; 46: 1129-33.

  3. Cañones P, Cano J, Cerezo E, Duran F, Encinas A, Fuster C, Sousa A. Enfermedades Inflamatorias Intestinales. Curso de Habilidades en Patología Digestiva. Sociedad Española de Medicina General, 1999: Cap 12:159-66.

  4. Carmen Moreira A. Enfermedad de Crohn y colitis ulcerosa. En: Centro Asistencial asepeyo-vigo, editor: Intituto de formación continua universidad de Barcelona, edición: 2006-2007.

  5. Crohn’s & Colitis Foundation of America 386 Park Avenue South 17th Floor New York, NY 1001.

  6. Farmer R. Tratamiento Médico de la Enfermedad Inflamatoria Intestinal. Temas Clinico-Terapeuticos en Gastroenterologia-1999; Cap 4:49- 68.

  7. Fry RD, Mahmoud N, Maron DJ, Ross HM, Rombeau J. Colon and rectum. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 50.

  8. Gionchetti P,Rizzello F,Lammers Km,Morselli C,Sollazzi L, Davies S, Tambasco R, Calabres M. and Probiotics in Treatament of Inflamatory Bowel Disease. World J Gastroenterology, June 2006; 12 (21):3306-13.

  9. Guillén Rodríguez M. Enfermedad de Crohn. Revista Médica de Costa Rica Centroam; 69(601):153-6, abr. 2012.

  10. Hinojosa del val J, “Enfermedad inflamatoria crónica intestinal. ¿cómo y cuándo sospecharla?”. Principios básicos de gastroenterología para médicos de familia-2ª edición 2002; CAP 25:391-407.

  11. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Inflammatory Bowel Disease in Children and Adolescents: Recommendations for Diagnosis. The Porto Criteria. J Pediatr Gastroenterol Nutr, 2005; 41:1–7.

  12. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104(2):465- 483.

  13. Lichenstein GR. Inflammatory bowel disease. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 143.

  14. Méndez JC. Exploraciones baritadas: enfermedad de Crohn del colon. En: Ramos L, editor. Diagnóstico radiológico de la enfermedad inflamatoria intestinal. Atlas iconográfico. Madrid: Esquema de comunicación S.A., 2000; p. 111-37.

  15. Mendoza J, Lana R, Taxonera C, Alba C, Izquierdo S, Diaz M. Manifestaciones Extraintestinales de la Enfermedad Inflamatoria Intestinal: Diferencias entre la Enfermedad de Crohn y la Colitis Ulcerosa. Medicina Clínica, Septiembre 2006; 125(8):297-300.

  16. Merdechilin Hernandez G, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn disease. Experience with 1379 patients. Ann surg 1991; 214: 230-8.

  17. Mendoza J, Lana R, Diaz M. Importancia De Las Mutaciones Del Nod2/Card15 en la Enfermedad de Crohn. Revista Clinica Española, Diciembre 2004; 204(12):642- 4.

  18. Sands BE, Siegel CA. Crohn’s disease. In: Feldman M, Friedman LS, Brandt LJ, eds.Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 111.

  19. Sans M. Enfermedad de Crohn. Enfermedades Hepáticas y Digestivas. Gastroenterol Hepatol. 2008;31(Supl4):47-50.

  20. Servicio de Medicina Interna, Hospital Clínico de la Universidad de Chile, Servicio de Gastroenterología, Clínica Las Condes, Sección de Gastroenterología, Servicio de Cirugía, Hospital Clínico de la Universidad de Chile, Santiago de Chile. Edición 2010-2012.

  21. Sicilia B, Vicente R, Gomollón F. Enfermedad de Crohn y colitis ulcerosa: Discusión de la epidemiología clásica. Acta Gastroenterológica Latinoamericana 2009;39:135-145.

  22. Van Assche G, Dignass A, Reinisch W, et al, for the European Crohn´s and Colitis Organization (ECCO). The second European evidence- based consensus on the diagnosis and management of Crohn´s disease: Special situations. JCC. 2010;4:63- 101.




2020     |     www.medigraphic.com